These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9082681)

  • 1. [New aspects of differential therapy of arterial hypertension with beta-blockers].
    Schwartzkopff B; Strauer BE
    Z Kardiol; 1996; 85 Suppl 7():31-4. PubMed ID: 9082681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical aspects of use of beta-blockers in the treatment of arterial hypertension].
    Widimský J
    Vnitr Lek; 1997 Apr; 43(4):221-5. PubMed ID: 9601840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic novelties in the management of arterial hypertension].
    Santamaría Olmo R
    Nefrologia; 2008; 28 Suppl 5():131-7. PubMed ID: 18847432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta-blockers and arterial hypertension. Evidence-based medicine or excessive perseverance?].
    Verdecchia P; Angeli F; Achilli P; Castellani C; Repaci S; Ambrosio G
    G Ital Cardiol (Rome); 2007 Sep; 8(9):552-8. PubMed ID: 17972424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta blockers in the treatment of arterial hypertension].
    Spinar J; Vítovec J
    Cas Lek Cesk; 1998 May; 137(9):278-81. PubMed ID: 9650357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta blockers in therapy of hypertension. For obese patients only the second choice? (interview by Dr. Beate Schumacher)].
    Sharma AM
    MMW Fortschr Med; 2001 Apr; 143(17):10. PubMed ID: 11490499
    [No Abstract]   [Full Text] [Related]  

  • 8. [Risk factors to be considered at the beginning of antihypertensive therapy in diabetes mellitus].
    Jermendy G
    Orv Hetil; 2004 May; 145(18):949-56. PubMed ID: 15188641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
    Kukes VG; Ostroumova OD; Mamaev VI; Batutina AM; Abakumov IuE; Zykova AA
    Ter Arkh; 2003; 75(8):43-7. PubMed ID: 14520850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome in hypertension: European society of hypertension position statement.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
    J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular protection using beta-blockers: a critical review of the evidence.
    Bangalore S; Messerli FH; Kostis JB; Pepine CJ
    J Am Coll Cardiol; 2007 Aug; 50(7):563-72. PubMed ID: 17692739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.
    Bangalore S; Parkar S; Grossman E; Messerli FH
    Am J Cardiol; 2007 Oct; 100(8):1254-62. PubMed ID: 17920367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential therapeutic aspects of high blood pressure therapy with beta blockers].
    Bühler FR; Bolli P
    Schweiz Rundsch Med Prax; 1983 May; 72(20):684-90. PubMed ID: 6136031
    [No Abstract]   [Full Text] [Related]  

  • 14. [Beta-receptor blockers: metabolic actions and therapeutic consequences (author's transl)].
    Lohmann FW
    MMW Munch Med Wochenschr; 1981 Nov; 123(47):1795-8. PubMed ID: 6118833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
    von Fallois J; Faulhaber HD
    Praxis (Bern 1994); 2001 Mar; 90(11):435-41. PubMed ID: 11293936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
    Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
    Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on intervention in arterial hypertension. Recommendations by experts and practical antihypertensive therapy. German Hypertension League].
    Trenkwalder P
    Fortschr Med; 1999 Feb; 117(6):24, 25-8, 30 passim. PubMed ID: 10095298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension].
    Lydtin H
    Med Welt; 1975 Aug; 6(35):1487-92. PubMed ID: 240998
    [No Abstract]   [Full Text] [Related]  

  • 20. [New aspects of antihypertensive therapy].
    Wedler B; Börner H; Schulz H; Teichmann G
    Ann Acad Med Stetin Supl; 1978; Suppl 16():9-12. PubMed ID: 44441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.